ReviewCurrent drug targets2026

MET Exon 14 Skipping Mutation in NSCLC: From Genomic Discovery to Biomarker-Guided Therapeutic Innovation.

Xiang Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.